Honz Pharmaceutical Co., Ltd., is a publicly listed company centered on medicines for children. It devotes to becoming the leading brand in the children’s healthcare industry in China.
Honz Pharma has five highly automated and intelligent manufacturing bases in Hainan, Beijing, Hebei, Liaoning, and Guangdong, and is constructing a new manufacturing base meeting the EU GMP standards in Zhongshan, Guangdong.
Honz Pharma emphasizes the R&D and innovation of products, has dedicated advanced equipment and exceptional R&D staff, and has invested hundreds of millions of RMB in this field.
Honz Pharma has formed an integrated structure of products, created a successful line of children’s medicines centered on “Honz” branded products, and launched unique Honz star products such as “Ruizhiqing”, “Kangzhisong”, “Kangzhitai”,and “Jinlishuang”.
2011, Honz Pharma jointly founded the Honz Healthy Growth Foundation with the China Children and Teenagers Foundation, with the mission statement of taking care of the healthy growth of children.
Honz will carry on the cooperate legacy of “Sincere, Caring, Innovative”, and shoulder the responsibility of caring for and supporting children’s health and well-being.
Medicine for Adults
Ceftazidime and tazobactam sodium for injection （3:1）
Kangruixin
Preferred new choice for moderate and severe infection of empiric therapy
Treatment in infection of body system, with broad-spectrum, strong anti-bacterial effect.
Strong antibacterial effect and solve the drug-assistant issues effectively
The latest generation of composite antibiotic with scientific formula 3:1
Safety of medication is high and less side effects
Ruipule
Wechat Account：honzpharma
Your position is：
